STAR0603 / Marengo - LARVOL DELTA

Marengo Therapeutics Announces Second Drug Candidate Nomination from Strategic Collaboration with Ipsen (PRNewswire) - "Marengo Therapeutics, Inc...announced that Ipsen...has nominated a second drug candidate (DC) under its multi-year strategic oncology collaboration with Marengo....Under the terms of the agreement, Marengo will receive a milestone payment for this pre-defined pre-clinical milestone. Per the agreement, Marengo has led research and preclinical development efforts in partnership with Ipsen. Ipsen will assume responsibilities for IND filing, regulatory submissions, clinical development and commercialization."

New molecule • Oncology